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Pulsed gradient spin-echo nuclear magnetic resonance diﬀusion
measurements have been used to show that platinum(II)-based
intercalating agents self-stack in solution and form nanorods
0.45–3.9 nm in length (at 25 mM); their lengths are dependent on
metal complex concentration, salt concentration and solution
temperature.
The anticancer agent 56MESS [(5,6-dimethyl-1,10-phenan-
throline)(1S,2S-diaminocyclohexane)platinum(II)]2+, Fig. 1a,
is our lead candidate in a family of over 60 platinum(II)-based
DNA intercalating complexes.1–4 It has demonstrated signiﬁ-
cant in vitro cytotoxicity in cisplatin sensitive and resistant
human cancer cell lines.5 56MESS is thought to induce cellular
apoptosis by intercalating double-stranded DNA, thereby
preventing DNA transcription and replication.1 Drug
transport, cellular uptake and intracellular glutathione
degradation6 are also thought to play a signiﬁcant role in
the structure–activity relationship of this family of platinum
complexes.1
A number of new platinum(II)-based DNA intercalator com-
plexes are also being developed that contain terpyridine inter-
calating groups (e.g. [(2,20:60,200-terpyridine)chloro-platinum(II)]+
[Pt(terpy)Cl]+; Fig. 1b).7–9 A number of these compounds display
activity similar to, or greater than, cisplatin in several cell lines.10
It is widely accepted that compounds that contain fused
aromatic rings are capable of forming dimers in solution through
favourable p–p stacking.11 Platinum(II) complexes containing
planar aromatic ligands have been shown to stack and form
dimers in aqueous solvents; however, these investigations have
been limited to one-dimensional 1H nuclear magnetic resonance
(NMR) and electronic spectroscopy.11–14 The formation of high-
er order aggregates (i.e. greater than two molecules) of these
compounds has not been well demonstrated. The self-assembly
of these complexes, particularly under physiological-like
conditions, is of great importance, as aggregation may inﬂuence
the ability of the complex to intercalate with DNA. In addition,
the formation of large aggregates may inﬂuence the rate of drug
transport/uptake.15
56MESS and [Pt(terpy)Cl]+ serve as excellent model
compounds for initial investigations of such aggregation
mechanisms. Thus, we have studied the self-aggregation of
56MESS and [Pt(terpy)Cl]+ at varying metal complex/salt
concentrations and solution temperatures using pulsed
gradient spin-echo (PGSE) NMR diﬀusion measurements.16
X-Ray crystal structures have shown that platinum(II)-
based DNA intercalators can p–p stack in three diﬀerent
conﬁgurations; a head-to-head,17 head-to-tail18 or pinwheel
conﬁguration, where alternate intercalator molecules are
rotated B901 compared to the molecule stacked above it.2
In any conﬁguration, the resultant macromolecule forms a
cylinder or rod-like structure. We have employed the simple
model of an ellipsoid (oblate or prolate, ESIw, Fig. S5) for the
determination of macromolecule length. By substituting the
observed diﬀusion coeﬃcient and the translational friction
coeﬃcient of an ellipsoid (oblate or prolate) into the
Stokes–Einstein equation,19 we have calculated the length of
the nanorod and the estimated number of stacked intercalator
molecules each contains (ESIw).
The comparison of the chemical shift (ESIw, Fig. S6) to the
diﬀusion coeﬃcient (Fig. 2) of 56MESS and [Pt(terpy)Cl]+
Fig. 1 The chemical structure of (a) 56MESS and (b) [Pt(terpy)Cl]+,
indicating the numbering system adopted.
Fig. 2 The diﬀusion coeﬃcient of 56MESS (’ 37 1C, 25 1C) and
[Pt(terpy)Cl]+ ( 37 1C, 25 1C) with increasing concentration.
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demonstrates that chemical shift change alone is not an
accurate method for determining the extent of aggregation.
The methyl resonance of 56MESS and the H5 resonance of
[Pt(terpy)Cl]+ experience the same magnitude (0.28 ppm) of
upﬁeld chemical shift with increasing concentration; however,
the reduction of the diﬀusion coeﬃcient diﬀers between the
two complexes (Table 1). The diﬀusion coeﬃcient of 56MESS
is reduced by 1.0  1010 m2 s1 (24%) and 1.3  1010 m2 s1
(22%) when the concentration in increased from 1 to 25 mM,
at 25 1C and 37 1C, respectively. This is compared to
the diﬀusion coeﬃcient of [Pt(terpy)Cl]+, which is reduced
by 2.1  1010 m2 s1 (25 1C, 48%) and 2.8  1010 m2 s1
(37 1C, 44%) over the same concentration range.y In addition,
the chemical shift of the methyl resonance at each metal
complex concentration is less sensitive to an increase in
temperature than the H5 resonance (B0.05 ppm compared
toB0.19 ppm). These results contrast the diﬀerences between
using diﬀusion and chemical shifts for probing the degree of
stacking, and show that measurement of chemical shift alone is
not a reliable method for determining the extent of aggrega-
tion. The diﬀusion coeﬃcient (Fig. 2) is more sensitive to
changes in molecule size due to aggregation, and in combina-
tion with the simple ellipsoid model, is a more appropriate and
extremely useful method for determining the size of stacks
formed.
At 25 1C, the diﬀusion coeﬃcients of 56MESS and
[Pt(terpy)Cl]+ decrease monotonically with increasing concen-
tration (Fig. 2, Table 1), indicating the formation of larger
particles. At the lowest concentration examined (1 mM) the
56MESS macromolecule containsB2–3 molecules, creating a
nanorod that is only 0.6 nm in length. At 25 mM, there are
B3–4 molecules in the nanorod, with a length of 1.0 nm
(Fig. 3a). [Pt(terpy)Cl]+, however, appears to self-stack to a
much greater extent than 56MESS, with nanorods 0.7–2.9 nm
(B3–10 molecules) in length formed as the concentration is
increased up to 25 mM (Fig. 3b). At high concentrations
(15–25 mM) the resonances of [Pt(terpy)Cl]+ also experience
a greater degree of broadening, supporting this ﬁnding of
aggregation.
The aggregation of both complexes was also examined at a
higher temperature (37 1C).z The higher temperature reduces
the size of the aggregates formed; at the lowest concentration
(1 mM) 56MESS does not appear to undergo stacking.
Between 2 and 10 mM the reduction in the diﬀusion coeﬃcient
suggests that some stacking does occur; however, it does not
change between 10 and 25 mM (Table 1), with the maximum
nanorod formed consisting of B2–3 molecules, with length
0.5 nm. [Pt(terpy)Cl]+ does not appear to have the same upper
limit on the size of the nanorod formed, with the diﬀusion
coeﬃcient continuing to decrease with increasing concentra-
tion (up to 25 mM). The nanorods formed are also longer
than those of 56MESS, consisting of a maximum of
B4–5 molecules, with a length of 1.2 nm. These results may
have implications in the delivery and transport of DNA
intercalating drugs, particularly platinum(II)-based drugs, in
disease treatment.
The eﬀect of salt concentration on nanorod formation was
also investigated, as the concentration of salt (NaCl) is
between 4 and 20 mM inside cells and as high as 155 mM in
intravenous drug infusions.20 Various experimental conditions
such as ionic strength,11,12 pH12 and counter-ion14 have been
shown to inﬂuence the self-assembly of platinum(II) inter-
calators. The incorporation of metal ions into solid-state
structures of platinum complexes has been shown to stabilise
the stacking of the molecules into columns.18 Conversely, it
has been shown that the addition of alkali metal salts
(especially NaCl) decreases the viscosity of D2O and
H2O,
21,22 which disrupts the hydrogen bonding between water
molecules, allowing solutes to diﬀuse faster through solution.
Under our experimental conditions, it appears that varying
Table 1 The diﬀusion coeﬃcients (D; 1010 m2 s1) and chemical
shifts (ppm) of 56MESS (methyl resonance) and [Pt(terpy)Cl]+ (H5
resonance) in D2O with increasing metal complex concentration and
solution temperature. Errors are given in brackets
[56MESS]/
mM
D
{25 1C}
d CH3/ppm
{25 1C}
D
{37 1C}
d CH3/ppm
{37 1C}
1.0 4.16 (0.01) 2.79 6.22 (0.02) 2.81
2.0 3.98 (0.01) 2.79 6.06 (0.02) 2.79
5.0 3.80 (0.01) 2.74 5.76 (0.01) 2.74
10 3.52 (0.02) 2.63 4.84 (0.01) 2.68
15 3.37 (0.01) 2.58 4.90 (0.01) 2.61
20 3.27 (0.01) 2.55 4.84 (0.01) 2.59
25 3.17 (0.01) 2.51 4.89 (0.01) 2.56
[Pt(terpy)Cl]+/
mM
D
{25 1C}
d H5/ppm
{25 1C}
D
{37 1C}
d H5/ppm
{37 1C}
1.0 4.36 (0.03) 7.64 6.31 (0.05) 7.81
2.0 3.90 (0.01) 7.58 5.60 (0.01) 7.77
5.0 3.28 (0.01) 7.52 4.89 (0.01) 7.70
10 2.99 (0.01) 7.48 4.42 (0.01) 7.64
15 2.61 (0.01) 7.45 4.06 (0.01) 7.59
20 2.47 (0.01) 7.37 3.76 (0.01) 7.56
25 2.26 (0.01) 7.36 3.52 (0.01) 7.53
Fig. 3 A schematic representation of the head-to-tail stacking at
25 1C of (a) the oblate (disk-like) model of 56MESS and (b) the
prolate (rod-like) model of [Pt(terpy)Cl]+ (no NaCl present).
Table 2 The diﬀusion coeﬃcients (D; 1010 m2 s1) and chemical
shifts (ppm) of 56MESS and [Pt(terpy)Cl]+ (20 mM, D2O, 25 1C) at
increasing concentrations of NaCl. Errors are given in brackets
NaCl/mM D 56MESS d CH3/ppm D [Pt(terpy)Cl]
+ d H5/ppm
0.0 3.27 (0.01) 2.55 2.47 (0.01) 7.37
2.0 3.26 (0.01) 2.55 2.40 (0.01) 7.35
5.0 3.26 (0.01) 2.54 2.34 (0.01) 7.34
7.0 3.26 (0.01) 2.54 2.30 (0.01) 7.33
10 3.24 (0.01) 2.53 2.23 (0.01) 7.31
15 3.22 (0.01) 2.52 2.16 (0.01) 7.30
20 3.22 (0.01) 2.52 2.10 (0.01) 7.29
35 3.17 (0.01) 2.49 ND ND
50 3.11 (0.01) 2.46 ND ND
65 3.10 (0.01) 2.45 ND ND
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NaCl concentration does not signiﬁcantly aﬀect the diﬀusion
of 56MESS, up to 1 : 1 equiv.; however, it does change over a
greater concentration range (Table 2, ESIw, Fig. S7).
The diﬀusion coeﬃcient of [Pt(terpy)Cl]+, however, decreases
signiﬁcantly with increasing NaCl concentration (up to 1 : 1
equiv.), with the chemical shift change of the H5 resonance
following a similar trend (ESIw, Fig. S8). As [Pt(terpy)Cl]+
diﬀuses much slower in solutions of higher NaCl concentra-
tions, it indicates there is an additional eﬀect that is more
signiﬁcant than the reduced viscosity of the solvent and may
be due to the facilitation of longer stack formation. It was
observed that the addition of NaCl to the solutions promoted
crystallisation, with the degree and speed of crystallisation
proportional to the concentration of NaCl. It is therefore most
likely that the addition of NaCl to [Pt(terpy)Cl]+ (20 mM)
promotes the self-stacking of the molecules, with the length
of the nanorod increasing from B2.9 nm to 3.9 nm. The
mechanism by which NaCl interacts with [Pt(terpy)Cl]+ in
the solution-phase is still unclear and is under further
investigation.
Despite 40 years of research, the mechanism by which plati-
num drugs (like cisplatin and carboplatin) are transported into
cells is still not clear. Cisplatin complexes are neutrally charged
(although they can become slightly cationic (1+ or 2+) upon
hydrolysis within the cell) and may only interact weakly with
negatively charged cell membranes. Both [Pt(terpy)Cl]+ and
56MESS nanorods, however, are more cationic (4+ to 12+)
at physiological temperature, and so may have stronger electro-
static interactions with cell surfaces. In addition, the nanorods
formed by 56MESS and [Pt(terpy)Cl]+ are of similar diameter
to some biomolecules (e.g. insulin B3.0 nm and cytochrome
CB4.0 nm).23 Tumour vasculature is known to have enhanced
permeability to macromolecules,15 which may have a positive
eﬀect on the uptake of 56MESS in cancerous tissues.
Overall, these results have implications not just in the delivery
of platinum-based DNA intercalating agents, but for all small
molecule drugs that contain fused aromatic ring systems, such
as doxorubicin and daunorubicin, which are routinely used in
the treatment of human breast cancers. These results are also
extremely relevant in the investigations of bis-intercalating
compounds and the interactions of these aggregates with
biomolecules. They also highlight the usefulness of PGSE
diﬀusion NMR in the measurement of aggregation of inter-
calating complexes, which will be the focus of further work.
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